• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ZymoGenetics

ZymoGenetics

  1. Blaze Bioscience Announces Trial in Progress Presentation at ASCO 2016 Annual Meeting

    Blaze Bioscience Announces Trial in Progress Presentation at ASCO 2016 Annual Meeting

  2. International Equity Commentary – December 2013

    ZymoGenetics has filed for approval of its first independently owned drug.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.